Search

Your search keyword '"Sabbe, Bernard"' showing total 1,053 results
Start Over Author "Sabbe, Bernard" Search Limiters Academic (Peer-Reviewed) Journals
1,053 results on '"Sabbe, Bernard"'

7. Substance Use in Forensic Assertive Community Treatment: Development and Implementation of a Pilot Project for Internees in Belgium.

Author

Marquant, Thomas, Van Nuffel, Meike, Sabbe, Bernard, and Goethals, Kris

Abstract

Substance use is a significant factor associated with new arrests, detentions and compulsory admissions for patients in forensic assertive community teams (FACT). To enhance community tenure for forensic patients and facilitate their sustainable integration into society, a treatment that offers a community-based alternative to admission following substance use was developed. In this paper, the development of the project, FENIX + is described along with the reporting of a pilot study of all included patients during 12 months (N = 24). Recidivism risk and community integration were assessed utilizing the Short-Term Risk Assessment and Treatability (START) as well as the Measurements in Addiction for Triage and Evaluation (MATE) scales. The included patients avoided 60% of admissions, exhibited positive changes in their desire for assistance, and successfully reduced their risk of recidivism. By accessing the community-based alternative, they were able to delay admissions effectively. These promising results suggest that a community-based treatment could benefit patients at risk of reoffending following substance use. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

8. Temporal Directionality Between Symptoms During Treatment of Depressed Inpatients: A Dynamic Time Warp Network Analysis.

Author

Cocx‐Swiebel, Daphne A., van Son, Gabrielle, Scheper, Anita, Stuivenga, Mirella, Sabbe, Bernard, Hebbrecht, Kaat, and Giltay, Erik J.

Subjects
RESEARCH funding, PSYCHOMOTOR disorders, PLEASURE, HOSPITAL care, QUESTIONNAIRES, TREATMENT effectiveness, INTERNALIZING behavior, LONGITUDINAL method, RESEARCH, DESPAIR, PSYCHOLOGICAL stress, MENTAL depression, TIME, PATIENTS' attitudes, PSYCHOSOCIAL factors
Abstract

Background: Depression is generally perceived from the perspective of the common‐cause disease model. However, the network perspective assumes mutual influence of individual symptoms and stresses the importance of investigating symptom dynamics. Gaining a better understanding of symptom dynamics within individuals might contribute to more effective treatments. Methods: Current exploratory longitudinal research studied the associations and directionality between 43 symptoms from the generic questionnaire Symptom Questionnaire‐48 (SQ‐48) using dynamic time warp (DTW) analyses, in which trajectories with similar time‐dependent patterns can be identified. Data from individuals were analysed first, yielding distance matrices for all symptom trajectories, after which the data were aggregated. Results: The 148 included patients were all admitted for the treatment of their clinical depression. Undirected DTW analyses of three patients with longer time series but otherwise randomly chosen showed large variability among individuals. Group‐level undirected DTW analyses showed numerous significant edges between symptoms, largely clustering symptoms according to the eight pre‐existing subscales of the SQ‐48. Group‐level directed DTW analyses showed five symptoms with significant outstrength: 'hopeless', 'restless', 'down/depressed', 'feeling tense' and 'no enjoyment', meaning that change in these key symptoms preceded change in other symptoms. Limitations: The 43 included symptoms of the SQ‐48 primarily focus on internalizing problems in severely depressed inpatients, potentially limiting generalizability. Conclusions: DTW networks provided us with five key symptoms based on the dynamics of symptom scores. Future studies could explore whether process‐based therapy targeted at symptoms with high outstrength might result in more effectivity as part of personalized treatment. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

12. The effect of the cultural formulation interview on therapeutic working alliance: A study protocol

Author

Brand, Alma, Groen, Simon, Destoop, Nathalie, Jongsma, Hannah, Ghane, Samrad, Sabbe, Bernard, van Velsen, Harry, van Houten, Kurt, Becan, Özlem, Al Alyan, Dhiya, Braakman, Mario H., Brand, Alma, Groen, Simon, Destoop, Nathalie, Jongsma, Hannah, Ghane, Samrad, Sabbe, Bernard, van Velsen, Harry, van Houten, Kurt, Becan, Özlem, Al Alyan, Dhiya, and Braakman, Mario H.

Abstract

Background: The Cultural Formulation Interview (CFI) is designed to improve understanding of patients’ mental health care needs. The lack of empirical evidence on the impact and effectiveness of CFI use in clarifying people’s perspectives, experiences, context, and identity, and in preventing cultural misunderstandings between migrant patients and clinicians, inspired this study. The objective is to examine the effect of the CFI on the strength of therapeutic working alliances, and the potential mediating or moderating role of perceived empathy. Materials and methods: A multicenter randomized controlled trial will be conducted, involving migrant patients, their confidants, and clinicians. The CFI will be administered in the intervention group, but not in the control group. Validated questionnaires will be used to assess therapeutic working alliances and perceived empathy. T-tests and linear regression analyses will be conducted to investigate between-group differences and possible mediating or moderating effects. Results: This study will indicate whether or not the CFI strengthens the therapeutic working alliance between patients and clinicians, as moderated and/or mediated by perceived empathy. Discussion: Research on the effect and impact of using the CFI in mental health care for migrant patients is important to clarify whether its use strengthens the therapeutic working alliance with clinicians. This can lead to a reduction in cultural misunderstandings and improve mental health care for migrant patients. The results may also be important for the implementation of the CFI as a standard of care. Ethics and dissemination: This research protocol was tailored to the needs of patients in collaboration with experts by experience. It was approved by the Ethical Review Board of the Tilburg Law School and registered in the Clinical Trials Register under number NCT05788315. Positive results may st

Published
2024

20. State-associated changes in longitudinal [18F]-PBR111 TSPO PET imaging of psychosis patients: Evidence for the accelerated ageing hypothesis?

Author

De Picker, Livia, Ottoy, Julie, Verhaeghe, Jeroen, Deleye, Steven, wyffels, Leonie, Fransen, Erik, Kosten, Lauren, Sabbe, Bernard, Coppens, Violette, Timmers, Maarten, de Boer, Peter, Van Nueten, Luc, Op De Beeck, Ken, Oberacher, Herbert, Vanhoenacker, Filip, Ceyssens, Sarah, Stroobants, Sigrid, Staelens, Steven, and Morrens, Manuel

Published
2019
Full Text
View/download PDF

31. Long-acting second-generation injectable antipsychotics for the maintenance treatment of bipolar disorder: a narrative review.

Author

Belge, Jean-Baptiste and Sabbe, Bernard G.C.C.

Subjects
ANTIPSYCHOTIC agents, BIPOLAR disorder, HOSPITAL care, PSYCHOSES, ARIPIPRAZOLE
Abstract

Non-adherence to medication significantly affects bipolar disorder outcomes. Long-Acting Injectable antipsychotics show promise by ensuring adherence and averting relapses. This narrative review sought to evaluate the efficacy of second-generation injectable antipsychotics in bipolar disorder through searches in Embase, MEDLINE, and PsycInfo for randomized controlled trials and mirror-image studies. Risperidone and aripiprazole Long-Acting Injectables demonstrated effectiveness in preventing mood recurrences compared to placebos in adults with bipolar disorder. They showed superiority in preventing mania/hypomania relapses over placebos but did not appear to significantly outperform active oral controls. Notably, active controls seem to be more effective in preventing depression relapses than Long-Acting Injectables. Mirror-Image studies point toward the reduction of hospitalization rates following LAI initiation. The available evidence points thus toward the efficacy of LAIs, especially in managing manic episodes and reducing hospitalizations, The current evidence does not however immediately support prioritizing LAIs over oral medications in bipolar disorder treatment. More high-quality studies, especially comparing LAIs directly with active controls, are crucial to gain a comprehensive understanding of their efficacy. These findings highlight the need for further research to guide clinicians in optimizing treatment strategies for bipolar disorder. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

41. Corrigendum to “Cognitive trajectories during and after electroconvulsive therapy in patients with MDE: Taking different perspectives” [J. Psychiatr. Res. 152 (2022) 132–140]

Author

Hebbrecht, Kaat, primary, Dejaeger, Marijke, additional, Giltay, Erik J., additional, Birkenhäger, Tom, additional, Sabbe, Bernard, additional, Verwijk, Esmée, additional, Obbels, Jasmien, additional, Schrijvers, Didier, additional, and Van Diermen, Linda, additional

Published
2023
Full Text
View/download PDF

44. An update on pharmacotherapy for recurrent depression in 2022

Author

Belge, Jan-Baptist, Sabbe, Amber C.F., and Sabbe, Bernard

Subjects
Pharmacology. Therapy
Abstract

IntroductionMajor depressive disorder remains a major challenge due to its biopsychosocial burden with increased morbidity and mortality. Despite successful treatment options for the acute episode, recurrence rates are high, on average four times in a life span.Areas coveredBoth pharmacological as non-pharmacological evidence-based therapeutic options to prevent and treat recurrent depression are discussed.Expert opinionAlthough some risk factors for recurrence are well known, better evidence is needed. Antidepressant medication should be continued after acute treatment at its full therapeutic dose for longer periods, at least 1 year. There are no clear differences between classes of antidepressant medication when treatment is focused on preventing relapse. Bupropion is the only antidepressant with a proven efficacy to prevent recurrence in seasonal affective disorder. Recent findings conclude maintenance subanesthetic ketamine and esketamine treatment can be effective in sustaining antidepressant effect following remission. Furthermore, the pharmacological approach must be integrated with lifestyle interventions, especially aerobic exercise. Finally, combining pharma- and psychotherapy seems to improve outcome. Network and complexity sciences will help to decrease the high recurrence rates of MDD by developing more integrative and personalized approaches.

Published
2023

45. Vormt ECT een risico op een recidief van cerebrovasculair accident?

Author

Tuytens, Björn, Goossens, Astrid, Yperzeele, Laetitia, van Diermen, Linda, Cras, Patrick, Sabbe, Bernard, Schrijvers, Didier, and Van Den Eede, Filip

Subjects
Human medicine
Abstract

Achtergrond Vanwege de hemodynamische veranderingen die optreden tijdens elektroconvulsietherapie (ECT), bestaat er een theoretisch verhoogd risico op een recidief van cerebrovasculair accident (CVA). Doel De wetenschappelijke evidentie aangaande het risico op een recidief-CVA bij een behandeling met ECT in kaart brengen. Methode Voor dit systematisch literatuuroverzicht werden de PRISMA-richtlijnen toegepast in PubMed en in de Cochrane Library. Artikelen waarin ECT werd beschreven bij patiënten met een voorgeschiedenis van CVA werden geïncludeerd aan de hand van specifieke zoektermen. Resultaten We vonden 19 artikelen: 1 grote en 1 kleine prospectieve studie, 3 kleine retrospectieve studies en 14 gevalsbeschrijvingen. In de grote longitudinale Deense studie was er globaal genomen geen verhoogde prevalentie van recidief- CVA bij de patiënten die behandeld werden met ECT. In de overige artikelen werd er ook geen verhoogd risico op CVA gerapporteerd. Conclusie Ondanks het beperkte aantal prospectieve studies en de methodologische beperkingen kunnen we voorzichtig besluiten dat een behandeling met ECT niet gepaard gaat met verhoogd risico op een recidief-CVA. ECT kan op een veilige wijze toegepast worden bij patiënten met een voorgeschiedenis van CVA, mits men zorgdraagt voor een grondige voorafgaande neurologische en cardiovasculaire diagnostiek en monitoring tijdens de behandeling.

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results